Springvest

Volare Solutions specializes in transforming industrial food waste into valuable, sustainable products. The company focuses on converting food waste into protein, oil, and fertilizer ingredients using black soldier flies. This process aims to replace environmentally harmful components like fishmeal, soy, and palm oil in feeds and the chemical industry. By doing so, Volare helps large food companies achieve their climate and nature goals, contributing to a more sustainable food chain.

Solar Foods Ltd., founded in 2017 and based in Lappeenranta, Finland, is a food-tech startup focused on producing sustainable protein alternatives through innovative technology. The company specializes in a process that utilizes electricity to generate hydrogen, which is then combined with carbon dioxide, water, vitamins, and minerals to cultivate microbial biomass. This biomass is transformed into Solein, a nutritious single-cell protein that serves as an alternative to animal-derived proteins. Solar Foods' method relies on elements from the air, such as CO2 and nitrogen, and is independent of traditional agricultural practices, making it resilient to climate variations. By employing gas fermentation, Solar Foods aims to provide a sustainable solution for food production that addresses the growing demand for nutritious food ingredients and plant-based meat alternatives.

Desentum Oy, established in 2011 and headquartered in Finland, is a biopharmaceutical company dedicated to developing innovative allergy vaccines. The company focuses on creating hypoallergenic vaccines targeting common allergens such as birch pollen, pet dander, and food proteins like fish and nuts. Desentum's unique approach involves designing vaccines that switch the immune system's response from hypersensitivity to tolerance, aiming to provide long-term relief for allergy sufferers while reducing societal burdens.

Solar Foods Ltd., founded in 2017 and based in Lappeenranta, Finland, is a food-tech startup focused on producing sustainable protein alternatives through innovative technology. The company specializes in a process that utilizes electricity to generate hydrogen, which is then combined with carbon dioxide, water, vitamins, and minerals to cultivate microbial biomass. This biomass is transformed into Solein, a nutritious single-cell protein that serves as an alternative to animal-derived proteins. Solar Foods' method relies on elements from the air, such as CO2 and nitrogen, and is independent of traditional agricultural practices, making it resilient to climate variations. By employing gas fermentation, Solar Foods aims to provide a sustainable solution for food production that addresses the growing demand for nutritious food ingredients and plant-based meat alternatives.

Kuva Space is a company focused on enhancing life on Earth through its extensive constellation of nanosatellites equipped with advanced hyperspectral imaging technology. By utilizing its GREEN DATA® platform, Kuva Space addresses critical global challenges such as climate change, disaster response, and food security. The company provides actionable data and insights that support sustainable management of natural resources, enabling clients to optimize agricultural practices, improve land use, and make informed investment and financial decisions. Additionally, its technology allows for the measurement of regional carbon sequestration rates, prevention of large-scale forest fires, and detection of gas leaks, all facilitated by an integrated artificial intelligence platform.

MedicubeX is a pioneering company in the field of preventive healthcare, focused on developing autonomous self-measurement and telehealth eHealth Stations. As the first advanced health kiosk in the Nordics, MedicubeX provides users with access to clinical-grade medical check-ups regardless of their location. Its eHealth Stations are designed to measure vital signs and assess risk factors, particularly concerning cardiovascular health. These stations facilitate healthcare automation, allowing users to conduct health check-ups in just a few minutes. With features such as automated umbilical venous catheter disinfection and options for privacy during remote appointments, MedicubeX aims to deliver scalable and accessible solutions for monitoring health status and enhancing preventive care.

Cerenion is a medical device company dedicated to improving outcomes for patients suffering from brain injuries resulting from medical emergencies such as strokes, cardiac arrests, and epileptic seizures. The company has developed C-Trend, a patented AI-based technology that facilitates rapid and reliable brain monitoring in hospital emergency and intensive care units. This innovative solution allows for the quick availability of EEG monitoring, enhancing patient care and enabling healthcare professionals to make informed clinical decisions. By processing complex electroencephalography data into simplified parameters, Cerenion's technology aims to improve both the quality of care and the cost-effectiveness of intensive medical treatments.

Desentum Oy, established in 2011 and headquartered in Finland, is a biopharmaceutical company dedicated to developing innovative allergy vaccines. The company focuses on creating hypoallergenic vaccines targeting common allergens such as birch pollen, pet dander, and food proteins like fish and nuts. Desentum's unique approach involves designing vaccines that switch the immune system's response from hypersensitivity to tolerance, aiming to provide long-term relief for allergy sufferers while reducing societal burdens.

Rocsole is an innovative company that specializes in tomographic process monitoring technology for industrial applications. Founded in 2012 and headquartered in Houston, Texas, Rocsole develops and markets advanced measurement and control instruments based on 3D-tomographic imaging and optics. Its offerings include sensors for real-time 3D imaging of multiphase flows, alongside services such as process optimization, piloting, and statistical inversion computing. The company provides tailored solutions for various industries, including oil and gas, food, chemical, and pulp and paper, addressing critical processes like scaling, air measurement, and interface detection. Rocsole's smart sensors leverage artificial intelligence and deep learning to deliver actionable insights, helping clients enhance operational efficiency, reduce costs, and minimize their environmental impact.

Bioretec Ltd. is a Finnish medical device company that specializes in the development, manufacturing, and marketing of bioabsorbable and bioactive surgical implants. These implants are designed for use in orthopedic, trauma, and sports medicine surgeries, catering to both pediatric and adult patients. Bioretec's products are recognized for their safety and reliability and are utilized globally. The company is committed to advancing materials and products suitable for high-load-bearing clinical applications. Notable brands associated with Bioretec include RemeOs, Activa IM-N, ActivaPi, and ActivaScrew.

Verto Analytics Inc. specializes in audience cross-platform measurement solutions that track consumer behavior across various devices, applications, and platforms. The company operates a passive metering panel that collects longitudinal data on user interactions, providing insights into daily usage patterns, content consumption, and demographics. Its offerings include Verto App Watch, which analyzes mobile application usage, and Verto Watch, which aids device vendors and carriers in understanding consumer behavior related to their products. Verto Content Watch helps publishers assess their reach and market dynamics, while Verto Index focuses on cross-device usage of travel websites. Additionally, Verto provides tools for measuring user retention and engagement, as well as custom research services. Established in 2013 and headquartered in New York City, Verto Analytics also has offices in San Francisco, London, and Helsinki, enhancing its ability to deliver comprehensive insights into the evolving landscape of digital media consumption.

Convion Ltd., established in 2012 and located in Espoo, Finland, specializes in the development and manufacturing of solid oxide fuel cell systems for power generation and hydrogen production. The company's technology facilitates the efficient conversion of various fuels into electricity and steam, promoting sustainable energy solutions. Convion's modular fuel cell systems are designed for flexibility, allowing them to operate with different fuel types and catering to both industrial and commercial applications. By focusing on high-efficiency energy conversion, Convion aims to enhance energy independence and security while providing reliable and operationally flexible solutions in the power generation market.

Mobidiag is a Finnish-French biotechnology company specializing in the development and marketing of molecular diagnostic solutions aimed at detecting gastrointestinal infections, antimicrobial resistance, healthcare-associated infections, respiratory infections, and sepsis. The company utilizes established technologies such as real-time polymerase chain reaction (qPCR) and microarray to create a wide array of diagnostic tests and automated platforms. These solutions are designed to be fast, reliable, and cost-effective, catering to laboratories of various sizes. Mobidiag's offerings enable the detection of a majority of clinically relevant pathogens, including bacteria, parasites, and viruses, as well as important markers for antibiotic resistance, thereby enhancing diagnostic capabilities in hospitals, laboratories, and clinics.

Finbiosoft is a company dedicated to creating software solutions that enhance the efficiency of clinical laboratories and diagnostic companies. Its flagship product, Validation Manager™, is a web-based platform designed to streamline the validation and verification processes for diagnostic tests. By automating and standardizing data handling, Validation Manager™ reduces the time and potential errors associated with these tasks. The software supports laboratory professionals and test manufacturers in conducting accurate evaluations, ultimately improving the quality of diagnostics. Finbiosoft's approach enables scientists to implement the most effective diagnostic tools with minimal resource expenditure.

Springvest is a crowdfunding platform based in Helsinki, Finland, established in 2012. It aims to streamline the financing process for promising Finnish growth companies, allowing them to focus on their business rather than spending excessive time on fundraising. By connecting these companies with investors seeking higher potential opportunities, Springvest facilitates financing rounds that empower businesses to capitalize on their ideas more quickly and effectively. The platform encourages Finnish investors to engage with local growth companies, fostering a community that supports innovation and potential success in the Finnish market.

Ductor is a Finnish biotechnology company focused on addressing climate change and food sustainability challenges through innovative technology. It has developed proprietary and patented methods for biologically producing ammonia and phosphates from recycled materials. This technology can be integrated into various applications, including algae farming, to enhance nutrient supply and energy production. Ductor has achieved a significant milestone by initiating industrial-scale production, with its first implementation designed to augment existing biogas facilities, thereby improving their economic viability. The company aims to provide sustainable organic fertilizers and renewable energy, supporting farmers and food producers in maintaining healthy soils and promoting ecological farming practices.

Desentum Oy, established in 2011 and headquartered in Finland, is a biopharmaceutical company dedicated to developing innovative allergy vaccines. The company focuses on creating hypoallergenic vaccines targeting common allergens such as birch pollen, pet dander, and food proteins like fish and nuts. Desentum's unique approach involves designing vaccines that switch the immune system's response from hypersensitivity to tolerance, aiming to provide long-term relief for allergy sufferers while reducing societal burdens.

The mariPOC® test system allows a multi-analytical result from one patient sample with one analysis. The test system provides central laboratory-level accuracy for patient-centered diagnostics. The reliability of the results is verified by automatic testing of the test system.

Ukkoverkot Ltd is a Finnish mobile data operator specializing in the production and marketing of wireless telecommunication services. The company operates a 450 MHz 4G LTE mobile data network that spans the entirety of Finland, catering primarily to businesses, authorities, and other demanding user groups. Ukkoverkot does not provide voice or SMS services, instead focusing solely on mobile data solutions. In addition to its nationwide offerings, the company delivers high-speed mobile network solutions designed for both continuous and temporary coverage needs.

Volare Solutions specializes in transforming industrial food waste into valuable, sustainable products. The company focuses on converting food waste into protein, oil, and fertilizer ingredients using black soldier flies. This process aims to replace environmentally harmful components like fishmeal, soy, and palm oil in feeds and the chemical industry. By doing so, Volare helps large food companies achieve their climate and nature goals, contributing to a more sustainable food chain.

CurifyLabs is a Finnish healthtech company established in 2021 by Charlotta Topelius and Niklas Sandler Topelius. The company specializes in developing 3D printing solutions for the personalized manufacturing of medicines, primarily within pharmacies and hospitals. CurifyLabs has created an automated on-demand manufacturing system known as "the Pharma Kit," which incorporates printable pharmaceutical inks to facilitate the mass customization of medications. This innovative approach enhances patient safety and treatment efficacy while significantly reducing costs. By streamlining the drug compounding process, CurifyLabs enables healthcare providers to tailor drug treatments to the individual needs of patients, thus improving overall treatment outcomes and promoting sustainable manufacturing practices.